Tauriga Sciences, Inc. to Present at Cannabis Investor Webcast on April 9, 2015
LOS ANGELES, April 7, 2015 /PRNewswire/ — Tauriga Sciences, Inc. (OTCQB:TAUG) (“Tauriga” or the “Company”), a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology will be presenting on the Cannabis Investor Webcast on Thursday, April 9, 2015 at10:00 AM EDT.
“We’re excited that Tauriga Sciences, Inc. has decided to present to our online audience of industry investors, analysts, executives, media, and consumers,” said Derwin A. Wallace, Senior VP of Investor Webcast. “The online interactive webcast will provide Tauriga Sciences, Inc. with increased awareness and exposure.”
The Cannabis Investor Webcast will include presentations from privately-held and publicly-traded industry companies and industry professionals. The Tauriga Sciences, Inc. presentation will be 30-minutes long and followed by 15-minutes of Q&A. The Cannabis Investor Webcast is a great opportunity for the audience to research industry companies without taking time-off from work, paying registration fees and incurring travel-related expenses.
“We are pleased to provide an overview of our company, of our newly launched natural wellness products and of recent developments through The Cannabis Investor Webcast’s online interactive platform. This will be the first of several Tauriga presentations in the next few months on the Cannabis Investor Webcast. The platform will enable us to reach a wide network of investors who may share our vision on the opportunities in the medical cannabis space,” states Dr. Stella M. Sung, Chairman and CEO of Tauriga Sciences, Inc.
Cannabis investors, analysts, executives, media, and consumers who would like to attend our free online webcast please click on the link http://www.cannawebcast.com/ and visit the Registration Page and to view the recording of the webcast please visitwww.youtube.com and search for Cannabis Investor Webcast two weeks after the live presentation.
About Tauriga Sciences, Inc.
Tauriga Sciences, Inc. (TAUG) is a diversified life sciences company focused on generating profitable revenues in the natural wellness sector and in developing a proprietary synthetic biology platform technology. The mission of the Company is to acquire and build a diversified portfolio of cutting edge technology assets that is capital efficient and of significant value to the shareholders. The Company’s business model includes the acquisition of licenses, equity stakes, rights on both an exclusive and non-exclusive basis, and entire businesses. Management is firmly committed to building lasting shareholder value in the short, intermediate, and long terms. Please visit the Company’s corporate website at http://www.tauriga.com and the Company’s e-commerce website atwww.taurigastore.com.
This press release does not constitute an offer to sell or the solicitation of an offer to buy any of these securities, nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale is not permitted. Any securities offered or issued in connection with the above-referenced merger and/or investment have not been registered, and will be offered pursuant to an exemption from registration.
Forward-Looking Statements: Except for statements of historical fact, this news release contains certain “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995, including, without limitation expectations, beliefs, plans and objectives regarding the development, use and marketability of products. Such forward-looking statements are based on present circumstances and on TAUG’s predictions with respect to events that have not occurred, that may not occur, or that may occur with different consequences and timing than those now assumed or anticipated. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, and are not guarantees of future performance or results and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results expressed or implied by such forward-looking statements. Such factors include general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to fund operations and other factors over which TAUG has little or no control. Such forward-looking statements are made only as of the date of this release, and TAUG assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. Readers should not place undue reliance on these forward-looking statements. Risks, uncertainties and other factors are discussed in documents filed from time to time by TAUG with the Securities and Exchange Commission. This press release does not and shall not constitute an offer to sell or the solicitation of any offer to buy any of the securities, nor shall there be any sale of the securities, in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. The securities have not been registered under the Securities Act of 1933, as amended (the “Securities Act”) or any state securities laws, and may not be offered or sold in the United States absent registration, or an applicable exemption from registration, under the Securities Act and applicable state securities laws.
Food and Drug Administration Disclaimer: None of the statements contained in this press release regarding any of the products either offered or to be offered in the future by the Company have been evaluated by the Food and Drug Administration. Additionally, none of the products is intended to diagnose, treat, cure, or prevent any disease.
Tauriga Sciences, Inc
SOURCE Tauriga Sciences, Inc.